Minner, S., Poos, A., & Rippe, K. (2019). Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2: ERG fusion type prostate cancers. The prostate, 79(3), . https://doi.org/10.1002/pros.23736
Chicago Style (17th ed.) CitationMinner, Sarah, Alexandra Poos, and Karsten Rippe. "Loss of CCAAT-enhancer-binding Protein Alpha (CEBPA) Is Linked to Poor Prognosis in PTEN Deleted and TMPRSS2: ERG Fusion Type Prostate Cancers." The Prostate 79, no. 3 (2019). https://doi.org/10.1002/pros.23736.
MLA (9th ed.) CitationMinner, Sarah, et al. "Loss of CCAAT-enhancer-binding Protein Alpha (CEBPA) Is Linked to Poor Prognosis in PTEN Deleted and TMPRSS2: ERG Fusion Type Prostate Cancers." The Prostate, vol. 79, no. 3, 2019, https://doi.org/10.1002/pros.23736.